Global Biological and Chemical Index Market : Industry Insights, Major Key Players and Current Trends Analysis

SDKI Inc. published a new report on "Global Biological and Chemical Indicator Markets-Forecast 2022-2030". This study includes the statistical and analytical approaches needed to grow the biological and chemical indicator market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-91612

The biological and chemical indicator market is estimated to reach US $ 701.17 million by 2030 from a market value of US $ 428.46 million in 2022, with a CAGR of 7.29% during the 2022-2030 forecast period. Expected to grow.

Biological indicators are defined resistance to a specific sterilization process. A test system containing viable microorganisms with. These help monitor whether the conditions required to kill a specified number of microorganisms in a particular sterilization process are met. Strict Good Manufacturing Practices (GMP) standards related to laboratory testing and finished product quality control are influencing pharmaceutical and biotechnology companies to incorporate sterility practices. It drives the demand for biological and chemical indicators.

In addition, using enzyme indicators as a surrogate for traditional biological indicators offers benefits such as rapid delivery of results, minimal economic loss, and reduced risk associated with biological indicators. Therefore, it creates demand for new indicators that drive market growth. The risk of infection during medical procedures is driving the demand for indicators as surgery increases the need for sterilization. Therefore, the increasing number of surgeries performed will drive the growth of the biological and chemical indicator market. In addition, the increased incidence of nosocomial infections (HAIs) will drive the growth of the biological and chemical indicator market. The Centers for Disease Control and Prevention (CDC) estimates that HAI causes approximately 1.7 million infections and 99,000 associated deaths each year in the United States alone.

However, inconvenience and long treatment periods can impede the growth of the biological and chemical indicator market during the 2022-2030 forecast period.

Sample URL for the report
https://www.sdki.jp/sample-request-91612

Biological and chemical indicator market segment

The biological and chemical index markets are by sterility type (heat sterility, chemical sterility, radiation sterility), indicator class (biological indicator, chemical indicator, enzyme indicator), and package form (self-contained BI, spores). It is divided into suspension BI, strip and disc BI, strip and disc CI, etc.), by end user (biopharmaceutical industry, hospitals, clinics, outpatient surgery centers, diagnostic laboratories, laboratories), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

Biological / chemical indicator market The biological / chemical indicator market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

North America is the world's leading region in terms of market share. This is due to the increased number of surgeries and the increased prevalence of HAI in the region. Meanwhile, the Asia-Pacific biological and chemical indicator market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030). Factors such as rapidly increasing infectious diseases create favorable growth opportunities for the bio-chemical indicator market in the Asia-Pacific region.

A major key player in the biological and chemical indicator market

Key players in the biological and chemical indicator market include Protak Scientific Ltd., Getinge AB, 3M Company, Steris Plc, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex. International Inc., Propper Manufacturing Co. Inc., GKE-GmbH and others. The study includes a detailed competitive analysis of these key companies in the biological and chemical indicator markets, company profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/global-biological-and-chemical-index-market/206

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.